Participating practices will learn about dental disease pathophysiology and diagnosis, gain insights in pet owner behaviour and learn how to increase client engagement while implementing a dental home care plan.
Animalcare has also made available free social media packs and waiting room materials to help educate clients on pet dental health.
Will Peel, Marketing Manager at Animalcare said: ‘We know that UK veterinary surgeons consider dental disorders to be one of the most important health related welfare issues currently affecting UK dogs.
"We’ve introduced our CPD sessions to help the entire veterinary team learn more about dental disease and to help them educate their clients about implementing an at home dental regime which works for them and their pets.'
To book your Lunch and Learn or request a social media pack and other materials, contact your local Animalcare territory manager or email animalcare@animalcare.co.uk.
A survey carried out by Intervet/Schering-Plough Animal Health to launch Plerion, a chewable, flavoured wormer for dogs, has shown that most UK dog owners turn to their vet rather than a pet shop for advice on worming.
Over 83% of owners who took part in the survey said they follow their vet's advice on worming whilst fewer than 8% would follow the advice of their local pet shop. 63% choose to buy wormers from their vet against 35% buying wormers from a pet shop or online pharmacy.
Survey participants understood the importance of carrying out a regular worming programme with almost 80% stating that a dog should be wormed every three to four months. However, some owners cited forgetfulness as a reason for not worming their pet regularly and expressed a need for a reminder from their local vet practice.
Almost 85% of those who took part in the survey believed that not all wormers provide the same level of protection and almost 75% said that vet recommendation is the reason they purchase a specific brand of wormer. 94% of owners are aware that worms can affect people as well as dogs.
The survey revealed that 1 in 5 owners experienced difficulty in administering a complete dose due to their dog spitting out part or the entire tablet.
Intervet/Schering Plough says that Plerion should help reduce compliance issues; its innovative and tasty soft chew formulation meaning that most dogs will take it right out of the hand.
Sarah-Jane Minter, marketing manager at Intervet/Schering-Plough said: "When developing Plerion we knew it was essential to launch a product that made life easier for dog owners by being easy, and even fun, to administer as this would increase the likelihood of owners sticking to a regular worming programme. We are delighted by the feedback we are receiving from owners who report their once fussy dogs are taking the flavoured, chewable Plerion tablets as though they were treats."
Plerion is available in two tablet sizes that provide a combination of Pyrantel, Praziquantel and Oxantel which, the company says, gives effective treatment for the major endoparasites in a single dose including tapeworm Echinococcus multilocularis, as required by the Pets Travel Scheme (PETS).
For further information, please contact your local Intervet/Schering-Plough Veterinary Business Manager or phone the company's Veterinary Support Group on 01908 685685.
Intervet/Schering-Plough has announced that the license for Leptavoid-H has been improved allowing concurrent use with Bovilis BVD.
Intervet/Schering Plough says that given both vaccines are typically administered in the busy pre-turnout period, this will ease on-farm workload and should help to ensure that all primary courses or boosters take place sufficiently in advance of the period of risk.
Each vaccine is to be given by separate routes and sites, to animals of 8 months or older. The concurrent use in cattle may result in fewer animal interventions, less stress and better welfare.
The studies, undertaken by Intervet/Schering Plough's R&D division in the UK, focussed on both the safety and efficacy aspects of the concurrent administration of Leptavoid-H with Bovilis BVD. The company says no systemic adverse events occurred, there was no effect on the outcome of pregnancy or milk yields and the efficacy in cattle was not compromised.
Leptavoid-H is licensed to reduce the shedding of Leptospira interrogans serovar hardjo in urine. Leptavoid-H is the only Leptospirosis vaccine licensed to improve herd fertility when Leptospira hardjo is the cause of herd infertility, and the only vaccine proven to protect stock against both strains in the UK.
National Veterinary Services has launched NVS Webshop, an online veterinary shop that practices can bolt on to their own website, or setup as a standalone online shop.
NVS says the shop, which is branded with your practice livery, includes the following features:
For more information visit: http://www.vet2pet.co.uk, email: salesandmarketing@nvs-ltd.co.uk or call 01782 770326.
The RCVS has removed 333 veterinary surgeons from the Register for non-payment of their annual renewal fees.
The final deadline for payment of the annual renewal fee passed on 31 May and the RCVS has written to those who have not paid to inform them of their removal from the Register. In 2013, 369 veterinary surgeons were removed from the Register for non-payment.
A list of the veterinary surgeons who have been removed - and who have not been subsequently restored to the Register - has today been published on the RCVS website (www.rcvs.org.uk/vetremovals2014).
This list is published to alert those veterinary surgeons who have not responded to RCVS communications to check their registration status, and to remind employers to check the registration status of their employees. The registration status of any veterinary surgeon or veterinary nurse can also be checked online at www.rcvs.org.uk/check-the-register.
Any veterinary surgeon whose name appears on the list who believes they have paid their fee should contact the RCVS Finance Department as soon as possible on 020 7202 0723.
Veterinary surgeons and employers are reminded that, under the Veterinary Surgeons Act, it is illegal to allow anyone who is not on the RCVS Register to practise veterinary surgery. They can also no longer use the postnominal 'MRCVS' and any professional indemnity insurance the veterinary surgeon may have is also rendered invalid.
Further information about restoration to the Register, and a restoration application form, can be found at www.rcvs.org.uk/registration or by contacting the Registration Department on membership@rcvs.org.uk or 020 7202 0707.
In order to be restored to the Register, veterinary surgeons must pay a fee of at least £299, in addition to the outstanding annual renewal fee. The restoration fee increases each successive year a removed member remains off the Register.
The sessions will allow members of the profession to find out about upcoming College projects and put questions to the RCVS Officer Team, RCVS Council members and senior staff, in a friendly, informal atmosphere.
The first event is taking place at the Hilton Glasgow on William Street at 6:30pm, where there'll be supper and drinks before the main event at 7:30pm, when RCVS President Melissa Donald, RCVS Treasurer Niall Connell, RCVS Senior Vice-President Kate Richards, Junior Vice-President Sue Paterson, VN Council Chair Matthew Rendle, RCVS Registrar Eleanor Ferguson and RCVS CEO Lizzie Lockett will update everyone on College activities and take questions.
The College says that the topics for discussion will be up to the audience but are likely to include workforce issues, the review of RCVS guidance on under care, proposals for legislative reform, VetGDP and the future of extra-mural studies.
Melissa said: “In my opening speech as RCVS President I said that one of the key missions of my presidential year was to talk – and especially listen – to as many members of the professions as I possibly can.
“Relaunching our question time programme after a hiatus will give me the opportunity to do exactly this, as well as giving members of the professions that all-important opportunity to put their questions and concerns directly to us.
"We might not be able to address every problem, but these events give an excellent opportunity for vets and nurses to raise issues, forge connections with their peers and work together to find solutions.
“I hope that many of you will be able to come to our first in-person event in Glasgow but we will also be holding these question times virtually in the future for those people who may struggle to make it to these evening events.
"Rest assured – if you want to be heard, we will find a way to listen.”
The next in-person event is due to take place in Nottingham in January 2023 while the first virtual question time will take place in November 2022.
To register for the Glasgow event visit: tinyurl.com/22pem3d6
Following supply issues over the past 12 months, the company has gained regulatory approval to begin supplying Aqupharm through a new manufacturer.
Will Peel, marketing manager at Animalcare said: "We are aware of the challenges vets have faced over the past 12 months due to the shortage in supply, so we have been working hard to manage stock availability, however we are pleased that we are now able to supply the product on demand.
"We’d like to thank all our customers and wholesalers for their support and patience over the past year."
All existing Aqupharm products are available to order except Aqupharm no.3 which has been discontinued due to low market demand.
For product advice, contact: technical@animalcare.co.uk.
For further information or for orders, contact your local Animalcare Territory Manager or email animalcare@animalcare.co.uk.
https://www.aqupharm.co.uk
Fort Dodge, which supplies Bluetongue vaccine in continental Europe, has licensed its cattle vaccine in the UK and is now launching the product onto the UK market.
The company has already won and met tenders from several European governments, including France, Spain, Italy, Portugal Germany, Switzerland, Belgium and the Czech Republic for its Zulvac 8® Bovis vaccine and says it is the only international company to have produced vaccines for the most commonly occurring serotypes of the disease including 8, 4 and 1.
Approved by the VMD with a Provisional Marketing Authorisation, Zulvac 8 is available in 50 dose and 10 dose packs. The key claims are active immunisation against Bluetongue serotype 8 of cattle from 2.5 months old and a significant reduction of viraemia.
The vaccine is administered in 2 x 2 ml doses at three week intervals given by intra muscular injection and the product is supported by a fixed 2ml multidose applicator with Sterimatic needle protector and cleaning system to ensure accurate dosing and hygienic conditions.
John Hanley, Managing Director of Fort Dodge UK, said: "We were first to market with our Zulvac 8 product in three European countries and have received an Award for Agricultural Merit from the Spanish Government for our work in Bluetongue control. Following the licensing of Zulvac 8 Bovis in the UK we now have the opportunity to launch the product onto the UK market.
"In terms of pricing, Zulvac 8 is competitive per dose against other products in the market and it is supported by the experience gained in Europe with millions of animals already vaccinated. We're delighted that the VMD have authorised the vaccine and believe its availability can play a key role in protecting the UK's cattle from this dreadful disease."
The product is authorised for use by cattle farmers in the protection zone only, and will require veterinary prescription. Farmers can administer the vaccine to their cattle and the 2ml intra-muscular injection will be an advantage in aiding administration especially when used with Zulvac Bovis applicator with sterimatic needle protector and cleaning system.
The first batches will be available from veterinary wholesalers from week commencing 22nd September 2008.
A quick survey of VetSurgeon members1 has found that of those that didn't vote in the 2011 council elections, 37.9% 'did not believe that voting in the RCVS elections will have any impact on my working life'
However, as Wynne Richards pointed out, decisions made by the RCVS, or which have involved the RCVS have had a seismic impact on the profession over the years, things like:
... and so on, and so on.
So perhaps the issue is not whether or not the College is relevant to the working lives of its members. Clearly it is. More to the point, the College and its Councillors need to find ways to engage more with the profession and better demonstrate how the decisions it takes on the issues of the day will impact on its members.
This message is further hammered home by the 26% of voters who didn't vote because they: 'considered the candidates' manifestos / forum posts, but did not feel that any of the candidates deserved my vote'. Again, if the councillors had concentrated on explaining why their work would make a difference, perhaps that number could have been improved.
Of the remainder, 21% 'forgot', 8.7% 'didn't have the time to consider who to vote for, and vote', 4.9% gave other reasons. Again, all things which might be improved if members felt that the RCVS was relevant to their working lives.
1% 'weren't aware that the elections were taking place'.
One wonders if that 1% knows that Clement Attlee is no longer the Prime Minister.
1. VetSurgeon Poll 6th May - 8th August 2011. 103 respondents.
The RCVS Disciplinary Committee has reprimanded a veterinary surgeon for submitting a certificate of Clinical Inspection for Veterinary Inspectors ("TB52") for tuberculin tests he had undertaken on cattle, despite knowing that he had not fully complied with the standard operating procedures (SOP) for these tests.
At the outset of the three-day hearing, John Wilson admitted that, when acting as an Official Veterinarian (OV) he had not carried out tuberculin tests on cattle at a Wiltshire farm on 19 May 2011 strictly in accordance with the SOP required by the Animal Health and Veterinary Laboratories Agency (AHVLA), an executive agency of Defra.
The admitted shortcomings were that on 19 May, the second day of testing, Mr Wilson had failed to confirm the identity of all the animals, failed to inspect the animals digitally (ie using his hands) and had not measured the fold of skin at the injection site of all the animals. The College argued that this was contrary to the directions of the AHVLA and, in subsequently signing the TB52 certificate, he was either dishonest or should have known that the certification was incorrect. Mr Wilson admitted that he ought to have known the certification was incorrect but denied dishonesty, because he believed that he had conducted the test in a satisfactory manner and had correctly identified all the reactors in the herd.
Mr Wilson was a veterinary surgeon of over 40 years experience and unblemished record, and the Committee found his account of events to be accurate and honest. He said the farm involved was unprepared and test arrangements were chaotic, with poor handling facilities, and he would have been concerned for the safety of the animals and their handlers if he had complied fully with the SOP. He had advised the farmer to delay the test but his advice was rejected.
The Committee accepted that the testing had been carried out under exceptional and difficult circumstances. It noted that Mr Wilson had identified a reactor and taken appropriate actions, knowing that the outcome would be the quarantining of the whole herd. He had made no financial or other gain, other than the nominal fee charged for the work. Although failing to comply with the SOP fell short of what was expected of a veterinary surgeon, because of these circumstances, and as he had acted in what he considered to be the best interests of the animals and personnel, these actions did not amount to serious professional misconduct.
The Committee found that, even allowing for these difficulties and concerns, in signing the TB52 certificate a few days later, without any qualification, Mr Wilson ought to have known that it was incorrect, and his actions fell far short of the standards expected of the veterinary profession. They did not however find that he had been dishonest.
The Committee stressed the importance attached to accurate and reliable certification, in maintaining the confidence of the public and the profession, and in ensuring animal welfare.
Professor Lees, chairing and speaking on behalf of the committee said: "The Committee is aware, as confirmed by AHVLA, that this is a single, isolated event and the first offence in some 40 years of the Respondent working as a LVI [local veterinary inspector] or OV. After considering all the mitigating factors.and, given the exceptional circumstances of this specific case, the decision of the Committee is to reprimand Mr Wilson."
A new study1 lead by led by Dr Séverine Tasker at the University of Bristol's School of Veterinary Sciences and published in the journal Clinical and Vaccine Immunology (CVI), has shown that cats previously infected with the blood-borne bacteria M. haemofelis develop immunity from re-infection.
Haemoplasmas are a group of blood borne bacteria found in a wide range of mammals, including domestic and wild cats, and can cause severe anaemia. The findings of the new study have significantly advanced researchers' knowledge of immunity for these pathogens.
Information about the immune responses that occur in animals following haemoplasma infection is relatively unknown, largely due to the fact that researchers struggle to study these bacteria as they are unable to grow them in the laboratory. Antibiotics do not consistently clear infection and without correct treatment the anaemia can be fatal. Recently haemoplasma associated anaemia has been reported in a human too.
The aim of the study was to determine whether cats who had previously recovered from M. haemofelis infection were protected from re-infection. The researchers found that they were, representing a significant advancement in scientists' knowledge of immunity for haemoplasma infections.
The exact methods of protective immunity could not be clearly identified despite extensive investigations, but the study's results suggest that a vaccine, using a weakened form of the bacteria, may offer protection against haemoplasma infection.
Séverine said: "This is the first study to demonstrate protective immunity against M. haemofelis reinfection and it provides important information for a possible future haemoplasma vaccine.
"Our findings could help prevent the disease in cats and could also be of particular importance to farm animal species where haemoplasma infections can cause huge financial losses."
The study recommends future research should explore whether the bacterial animal infection could be transmitted to humans and how the immune system targets the pathogen.
Reference
According to the company, participating practices more than doubled the number of blood pressure checks they conducted, within 12 months.
The CVS’ clinical improvement project initially looked at how effective its first opinion small animal practices were in screening older cats for hypertension.
In line with the veterinary industry norm, it found that less than two per cent of cats over the age of seven were receiving an annual blood pressure check.
This initial research also found that the common barriers to conducting blood pressure checks by vets and veterinary nurses in practice were due to time constraints, availability of equipment and simply remembering to discuss blood pressure checks with owners.
Each CVS site chose two people to lead the initiative at their site, to aid communication and delivery.
A document was created to help, providing background, aims, summary of resources and planning sections.
Contributory factors preventing delivery of blood pressure checks were outlined and practices were encouraged to identify additional barriers and resources needed.
A suite of resources were then produced to support the practice team - from reception to veterinary surgeons - in improving annual blood pressure check rates.
The resources included new clinical frameworks and veterinary guidelines on how to treat hypertension; in-practice educational resources to highlight the benefits of hypertension screening and information sheets and blood pressure diaries to help clients manage their pets condition.
To upskill and develop colleagues in how to identify and treat hypertension and resulting conditions, a collection of training materials was created and training sessions held.
These included a series of webinars which explained why hypertension is important to identify, how to overcome common challenges encountered when looking for hypertension in cats, how to use the ophthalmic exam to help diagnose hypertension and how to treat hypertension.
Three in-person CPD days were hosted with the support from Ceva six months into the project where feline specialists Sarah Caney and Samantha Taylor shared the latest evidence base in this field and practices were encouraged to share barriers, queries and tips, so that ideas could be taken away to make blood pressure screening a simpler process in practice.
Practices were also encouraged to organise lunch and learn CPD sessions, to share best practice and generate discussion within their team.
In addition, a website was created to host all resources in one place, including webinars, clinical frameworks, client resources, a discussion forum and data.
An audit of each participating practice’s blood pressure check data was conducted at the start of the project.
Results were then shared with each participating practice every month - including the total number of blood pressure checks performed each month and the percentage of cats over the age of seven who had an annual blood pressure check.
Twelve months after its nation-wide launch, results reveal that the number of blood pressure checks have more than doubled (110%) within participating CVS practices and an additional 5,984 blood pressure checks have been performed year on year.
A number of practices were able to implement systems that allowed them to perform over 40 blood pressures each month.
The number of cats on amlodipine (the first choice medication to treat hypertension in cats) increased by 303 patients year-on-year, hinting many more cats had been diagnosed with hypertension.
Kate Allgood, Hub Clinical Lead at CVS who was responsible for the hypertension clinical improvement project, said: “There is a huge benefit in treating hypertension.
"No one wants to see a cat suddenly become blind due to hypertension that wasn’t recognised in time.
"So many associated longer-term feline complications and conditions can be avoided if annual blood pressure checks in cats over the age of seven are routinely performed.
"Increasing blood pressure screening is not a simple task though, and this focus has allowed space and time for practices to give this topic the recognition it deserves; to identify and implement systems that make it easier to identify patients at risk, discuss with clients and perform these checks with ease.
"We have created a robust clinical structure, produced some easily accessible materials and supported our practices to make small and simple changes that add up.
"Our practices have done an outstanding job at delivering this project to date and I look forward to seeing what can be achieved in the future. We strongly believe that this work will contribute towards providing some of the best clinical care for cats in the veterinary profession.”
Data for 2023 from UK Pet Food research found that around 5% of UK households own a reptile, up from 3.4% in 2022.
The new leaflets have been created using information from the BSAVA Manual of Reptiles and reviewed by Simon Girling, reptile specialist at The Royal Zoological Society of Scotland.
They cover things like housing, feeding, handling, medication and spotting health concerns, and are now available for veterinary surgeons to download and print out for clients thinking about getting a reptile.
There are currently leaflets for the following species:
BSAVA members can download the leaflets free from the BSAVA library.
Subscription access for 12 months to BSAVA’s collection of over 170 client information leaflets is available to non-members for £40+VAT here.
Free-range table-birds being reared from slower growing breeds need a different vaccination regime from that of faster-growing broilers, when being immunised against Gumboro disease.
This previously-unknown fact has emerged from laboratory and field trials, involving several hundred thousand birds on farms throughout the UK, carried out by Lohmann Animal Health in conjunction with poultry vets.
"When using a ‘hot' vaccine conventional broilers in the UK are normally vaccinated at around 14-16 days when their maternal immunity is waning," said Adam Goddard, Lohmann's UK sales consult. "However, we've found this maternal immunity lasts longer in the slow-growing breeds which are reared both indoors and out."
Realistically, the correct day of vaccination for free-range table-birds is more likely to be achieved by using the vaccine date predictions for broiler-breeders, rather than that of the broiler, under the Deventer formula, which gives calculations for different types of bird.
He therefore advises producers to consult their vets who can take blood samples to get an accurate prediction regarding optimum timing of vaccination with their own particular flocks.
"Our trials have shown that, in general, and depending upon the breed used, the decline in maternal immunity is delayed - perhaps for 4-5 days. So, in order to get a better ‘take', we recommend vaccinating these birds later or using an IBD vaccine that ‘takes' in the presence of high maternal immunity." said Mr Goddard.
Gumboro disease - also known as Infectious Bursal Disease - can cause severe losses in chickens and outdoor-reared birds are more susceptible to the disease due to environmental influences.
Earlier this year Lohmann Animal Health launched a new ‘hot' vaccine, classified as an ‘intermediate plus' against the very virulent form of Gumboro disease. The company says that because of its ability to break through high levels of maternal antibodies, it allows vaccination to take place earlier than with other existing vaccines.
BCF Technology is offering up to 35% off a variety of ultrasound and x-ray equipment until the end of February.
The offers are available on x-ray generators and ultrasound products such as the Medison Sonovet R3, GE C5 and Zonare.
For more information, visit the BCF website: www.bcftechnology.com, or ring 01506 460023.
Offers end 24th February and are subject to availability.
The RCVS Disciplinary Committee has dismissed an application to be restored to the Register of Veterinary Surgeons from a former Kent-based veterinary surgeon, Warwick Seymour-Hamilton.
Mr Seymour-Hamilton was originally removed from the Register in June 1994 for failing to maintain his equipment and facilities such that it evidenced a total disregard of basic hygiene and care for animals, thereby bringing the profession into disrepute.
The restoration hearing on Friday 18 March was Mr Seymour-Hamilton’s fourth application for restoration, with previous applications being submitted but refused in July 1995, June 2010 and January 2015. However, as the Committee made its decision on the merits of the case before it, those previous applications were not admitted as relevant to its decision.
Mr Seymour-Hamilton told the Committee that he currently works as a herbalist and naturopath for humans and wished to be restored to the Register so he could include animals in his research. He had completed a course in herbal and naturopathic medicine at the College of Naturopathic Medicine in Dublin in 2010, and told the Committee that he believed that being restored to the Register would lend credence to his endeavours to secure funding and other support. He stated that he did not intend to work again in a veterinary practice.
However, the Committee rejected his application on a number of grounds, including the impact on animal welfare should Mr Seymour-Hamilton be restored to the Register; the length of time he had been off the Register and the fact that he was therefore not up-to-date with contemporary veterinary practice and professional conduct; and that his efforts to keep up-to-date in terms of knowledge, skills and developments in practice were insufficient.
Judith Webb, chairing the Committee and speaking on its behalf, said: "The Committee is concerned about the length of time that has passed since he last practised and the paucity of the evidence he has provided to establish that, if permitted to return to practice, he would be able to attain the professional standards required of a modern veterinary practitioner, either as regards surgical capabilities/competence or as regards his knowledge of currently available veterinary medicines."
She added: "This Committee’s obligations and duties are to see that the interests of animal welfare are properly protected by ensuring that only those who are properly trained, knowledgeable and experienced are permitted to treat animals and that public confidence in the standards of the profession are maintained. The risks attendant on a restoration of this applicant to the Register are, in the judgement of this Committee, plain and obvious. Accordingly, this application is refused."
The company has introduced a new online range of pack inserts for several of its key products including Vetoryl, Felimazole, Metrobactin and Thyforon so veterinary practices can download and print the latest pack inserts for the treatments.
The move will ensure that practices always have access to the most up-to-date information about the prescribed medication. Dechra says it will also save time as staff will not have to copy original documents from the pack.
The pack inserts will be available via www.dechra.co.uk and www.dechra.ie. In addition, Dechra has developed dispensing envelopes which are available at no charge from wholesalers in packs of 25.
Larry King, Marketing Manager, said: "Veterinary practices often dispense pharmaceuticals from bulk which involves having to copy original pack inserts for owners.
"By printing the online pack inserts, practices will no longer have piles of inserts to store and will be safe in the knowledge they are supplying the most up to date pack insert to their clients.
"When used together, the pack inserts and dispensing envelopes provide practices with an effective solution when dispensing from bulk."
Running from 14th-23rd July, the interactive webinars will be delivered in 5 half-day sessions, led by UK pet food consultants, scientists, and vets.
The course includes:
Sarah Hormozi, PFMA Head of Science & Education, said: "With some of the most credible industry experts as our speakers, this is a rare opportunity for pet professionals across the UK and EU to improve and refresh their knowledge of animal nutrition, pet food legislation, marketing regulations and manufacturing methods, from the comfort of their own home or office!”
For the full programme, list of speakers, registration details and prices, visit www.pfma.org.uk/pfma-training-webinar-series.
The webinar is being hosted by Dr William Ingham Farrow from Poultry Health Services (PHS), part of the VetPartners group.
William said: “Having worked with a wide variety of different avian species and management systems for over 10 years, I’m delighted to be sharing my experience.
"I hope to bring plenty of useful insight to help young vets gain confidence in this area.
“In this session, I’m aiming to provide advice for first-opinion vets working with both individual hens and backyard flocks.
“I hope to show that you don't need specialist equipment or medication to offer veterinary care for these often overlooked clients, and to signpost the additional help available in more complex cases."
The webinar is part of the Farm Animal Veterinary Society's Car Pool Cases series, which will also cover antibiotic selection (June 25th), camelid care (August 20th), downer cows (October 22nd), youngstock (November 19th) and beef fertility (December 10th).
https://www.eventbrite.co.uk/e/carpool-cases-practical-pointers-from-front-line-farm-vets-tickets-640902997117
To submit questions ahead of the Carpool sessions, email: farmsupport@vetpartners.co.uk
www.favs.org.uk
For veterinary surgeons and VNs who missed out on the BVDA 'Improving Periodontal Health' lecture tour last year, a further six have been organised for this autumn.
Speakers include Norman Johnston BVM&S, MRCVS, Ex President of the European Veterinary Dental College, John Robinson BDS (Lond) Dentist to the Veterinary Profession and Lisa Milella BVSc, MRCVS President of the British Veterinary Dental Association (BVDA). This year's events see the content extended to include resorptive lesions, fractured teeth and dental radiography with greater emphasis on feline oral care.
According to Lisa, the 2010 lecture series helped alert vets and VNs to the importance of oral health, benefitting both pet and practice. "It takes five years at vet school to qualify yet only three or four days are devoted to dentistry, so it's no surprise that many vets and VNs enter the profession with only a basic understanding of oral health.
"We know that four out of five dogs over the age of three show signs of periodontal disease but unfortunately many go untreated. This is mainly because the problems that this can lead to are not fully understood."
She added: "These seminars will not only help delegates to recognise early signs of oral disease but also offer practical guidance on how practices can educate pet owners in the importance of oral care."
Lisa believes that both practices and owners benefit from good oral hygiene programmes. "As a profession we need to do more to help educate pet owners in the value of good oral care. Practices should be talking to their clients from day one about preventative programmes, rather than wait until the damage is done."
The six UK events are:
The evening seminars, which are open to both vets and nurses, contribute two hours CPD and cost £35 per person and £25 for each subsequent delegate. A special group rate of £100.00 is available for any practice that wishes to send a group of four. For anyone wanting to reserve a place, please call the BVDA lecture tour reservation line centre on 01664 415 503.
Virbac has announced that it is to increase production of cat vaccines at its French plants to help practices in the UK manage a shortfall in supply.
The predicted shortfall follows warnings by other manufacturers of stock shortages of between three and six months.
Virbac, which makes the Feligen RCP, Leucogen and Leucofeligen cat vaccines, says it wants to reassure practices that it will do its utmost to ensure continuity of supply during this period and is urging them to order as usual and not stockpile product, which could exacerbate the problem.
Simon Boulton MRCVS, Product Manager for Virbac's vaccine range, said: "Our priority is to keep stock flowing to our existing customers. With this in mind, we've now ceased to supply wholesalers with our cat vaccines. Once wholesaler stocks have been depleted, we ask customers to contact us directly so that stock can be despatched to them from our own warehouse.
By taking this step, we can manage our own stocks effectively and, while we'll be putting our existing customers first, we also stand ready to help supply the rest of the veterinary sector during this period. As a primary manufacturer of vaccines, we're well placed to react quickly to stock shortages and expect to have significantly increased supply by November."
Practices wanting further information should contact their Virbac Territory Manager. Direct orders to the company should be made by calling Virbac on 01359 243243 and selecting Option Three (Direct Orders).
Guernsey-based vet, VetSurgeon member David Chamberlain has officially launched a revolutionary cat flap which synchronises with a cat's microchip to control access to the house. The Pet Porte Microchip Cat Flap is the first cat flap that works in conjunction with microchips and has already been winning awards.
Aside from allowing only the homeowner's cats into the house, the Pet Porte Microchip Cat Flap has a number of other interesting features. ‘Vet Mode' allows recognised cats in, but does NOT allow them out, useful when a trip to the vet is on the calendar. ‘Night Mode' uses an automatic daylight sensor to lock the door as ambient light levels drop, keeping cats inside and safe. An audible beep (which can be turned off) provides an alert when a programmed cat enters though the flap.
The Pet Porte Microchip Cat Flap recognises 15 digit UK/European FDX-B microchips. Owners of cats that have already beed chipped can check check compatibility with the Pet Porte's 'Chip Checker'.
The cat flap can recognise up to 32 microchipped cats, and programming it is very simple. When the unit is first installed, the owner holds down a green paw button for ten seconds and passes their cat under the porch for the microchip to be programmed into the system.
A review on Pet Porte's website caught my eye:"Just like to say how absolutely fabulous the cat flap is. I've slashed my cat food bill now I'm not feeding the entire street!" On top of that, as Pet Porte says, this system also encourages microchipping, an important part of responsible pet ownership.
The Pet Porte microchip cat flap is currently being marketed in the UK through veterinary practices and online from http://www.petporte.com/. For all sales enquiries call 01481 265 359, email sales@petporte.com or visit www.petporte.com.
Alternatively, 'Start a Conversation' directly with David by clicking the link on his VetSurgeon profile.
Scientists from the Animal Health Trust, The Roslin Institute and the Royal (Dick) School of Veterinary Studies at the University of Edinburgh have launched a study which aims to create a diagnostic test that will allow breeders to assess genetic risk for hip and elbow dysplasia in their dogs.
Dr Sarah Blott, from the Animal Health Trust, said: "Currently the screening process for hip and elbow dysplasia is costly and requires dogs to undergo general anaesthetic so they can be x-rayed.
"Through our study we hope to create a non-invasive DNA-based test that will allow breeders to test much earlier than is currently possible and without the use of GA."
The Labrador Retriever is the most popular dog breed in the UK and worldwide. There were more than 40,000 puppies registered with The Kennel Club in 2010. The development of a DNA test will benefit dogs around the world by enabling breeders to make more informed breeding choices.
According to the Animal Health Trust, the introduction of a DNA test to identify genetic risk of hip and elbow dysplasia will:
Dr Pam Wiener, from The Roslin Institute, said: "We're very grateful to the BBSRC for funding this study. If we are able to gather enough information and samples there is a very real possibility that in the next few years we will be able to develop a DNA test that will make a major contribution towards eradicating hip and elbow dysplasia in Labrador Retrievers.
"It is also likely that we will be able to use what we learn from the Labrador Retriever study to benefit dogs of other breeds and to prevent other diseases."
To collect information for the study a simple questionnaire is being sent, through The Kennel Club, to owners of Kennel Club registered Hip Scored Labrador Retrievers who were born between 2004 and 2007. The study group is hoping to obtain questionnaires and samples from at least 2,000 Labrador Retrievers.
If you have a Kennel Club registered Hip Scored Labrador Retriever aged between four and seven years old and would like to participate in the study, please visit the AHT website (www.aht.org.uk/labrador.html) or email melissa.fitzgibbon@aht.org.uk
Once questionnaires have been received, the AHT will send each participant a DNA sampling kit to enable owners to provide a DNA sample from their dog through a simple mouth swab. Owners providing the first 1,500 analysed DNA samples will receive a free genetic profile for hip and elbow dysplasia on their dog.
DairyCo has announced the launch of a new programme designed to tackle the challenge of lameness on dairy farms.
The Healthy Feet Programme has been developed to provide a structured approach to assist vets and foot trimmers to work more closely with their farmer clients, to reduce the incidence of lameness on a permanent basis.
DairyCo product manager, Kate Cross said: "We've developed the programme to build on the DairyCo Mobility Score by introducing a programme that dairy farmers can undertake working with their vet who is a trained 'mobility mentor', to identify problems, risk factors and suitable intervention strategies on the farm. An action plan is then agreed to prioritise management practices that have a permanent impact on incidence of lameness."
The programme draws on the findings from the Bristol Healthy Feet Project, the New Zealand Healthy Hooves programme, First Steps and Claw Signals. As well as the valuable experience gained from the DairyCo mastitis plan. It has been designed to combine the best features of all these programmes and aims to build on the successful DairyCo Mobility Score.
Vets are invited to enrol for a two day CPD course, which will enable them to introduce the Healthy Feet Programme to their farmer clients and provide on-going support, assisted by a range of resources provided by DairyCo.
The first course is scheduled for June 2011
For further details please contact Kate Cross on 02476 478686 or email healthyfeet@dairyco.ahdb.org.uk
Boehringer Ingelheim Vetmedica has launched a competition to find 12 dogs that have responded well to treatment with Vetmedin, to feature in the company's forthcoming 2012 Better Dogs calendar.
Boehringer is particularly interested in hearing about dogs with funny or quirky stories, or ones that have made a dramatic heart-warming recovery. If the submission makes it to the short list of 12 they will be featured in Vetmedin's 2012 Better Dogs Calendar which will be available to veterinary practices later in the year. In addition, the vet with the best story will win a £250 Red Letter Days' voucher with the 11 runners up winning the new BSAVA Manual of Thoracic Imaging.
In return for pet owners agreeing to their dog's story being submitted, Boehringer will send each veterinary practice a complimentary pack of either Vetmedin 1.25mg x 50 tablets or Vetmedin 5.0mg x 50 tablets, depending on the normal prescription, to give to their client.
Entries can be made either on the 2012 Better Dogs Calendar form which can be found in a recent Vetmedin mailing or via email to vetmedin.bra@boehringer-ingelheim.com. All entries should be accompanied by a photograph. Terms and conditions apply and the closing date for submissions is 30 September 2011.
For further information, please contact your Boehringer Ingelheim Vetmedica Territory Manager or call 01344 746959.